New England Biolabs
Kristine Werling is a Development Scientist I at New England Biolabs, with prior experience as a Scientist II and I in Assay Development at Sherlock Biosciences, focusing on isothermal and CRISPR-based molecular diagnostics. Kristine served as a Postdoctoral Researcher at Penn State University, investigating an insect-specific virus for potential use as a viral vector, and held similar positions at Harvard T.H. Chan School of Public Health, where research targeted malaria parasites and mosquito interactions. Kristine's academic credentials include a PhD in Biological Sciences in Public Health from Harvard T.H. Chan School of Public Health and a BA in Environmental Science from Northwestern University.
This person is not in any teams
New England Biolabs
New England Biolabs produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing solutions supporting genome editing, synthetic biology and next-generation sequencing.